Cytodyn

Cytodyn

Cytodyn

CytoDyn is a biotechnology company focused on the development of new therapiesto combat infections with immune deficiency viruses.
Raised
$37.6M
Follow us
Alexa global traffic share
Twitter followers
11 May 2016
$4,300,000
Venture capital

SEC FORM D

sec
23 Feb 2016
$33,270,000
Post-IPO equity

SEC FORM D/A

sec